These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37932389)

  • 1. Added value of the EUSOBI diffusion levels in breast MRI.
    Zuiani C; Mansutti I; Caronia G; Linda A; Londero V; Girometti R
    Eur Radiol; 2024 May; 34(5):3352-3363. PubMed ID: 37932389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
    Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
    Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
    Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
    NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity.
    Arponen O; Masarwah A; Sutela A; Taina M; Könönen M; Sironen R; Hakumäki J; Vanninen R; Sudah M
    Eur Radiol; 2016 Dec; 26(12):4361-4370. PubMed ID: 27114285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study.
    Clauser P; Marcon M; Maieron M; Zuiani C; Bazzocchi M; Baltzer PA
    Eur Radiol; 2016 Jul; 26(7):2291-6. PubMed ID: 26443604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
    Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database.
    Bickel H; Clauser P; Pinker K; Helbich T; Biondic I; Brkljacic B; Dietzel M; Ivanac G; Krug B; Moschetta M; Neuhaus V; Preidler K; Baltzer P
    Eur Radiol; 2023 Aug; 33(8):5400-5410. PubMed ID: 37166495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
    Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
    J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers.
    Kishimoto AO; Kataoka M; Iima M; Honda M; Miyake KK; Ohashi A; Ota R; Kataoka T; Sakurai T; Toi M; Togashi K
    Magn Reson Imaging; 2020 Sep; 71():161-169. PubMed ID: 32320723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.